Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAB5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RAB5 is a protein involved in neurodegeneration research. Key relationships include: associated with, therapeutic target, expressed in. Associated with Aging, Als, Alzheimer. Connected to 278 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | RAB5A |
| Full Name | RAB5A, member RAS oncogene family |
| Chromosome | 3p24.3 |
| Function | encodes a critical small GTPase that serves as the master regulator of early endosome function. |
| Molecular Weight | 23.5 kDa |
| Amino Acids | 218 aa |
| Pathways | Apoptosis, Autophagy, Endocytosis, Mitophagy, VESICLE_TRAFFICKING |
| UniProt ID | P20339 |
| NCBI Gene ID | 5868 |
| Ensembl ID | ENSG00000112984 |
| OMIM | 171585 |
| GeneCards | RAB5A |
| Human Protein Atlas | RAB5A |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Ataxia, Dementia |
| Interactions | Albumin, ALS2, AND, ARHGEF7, ATG, ATG9A |
| KG Connections | 393 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
RAB5["RAB5
Rab5 GTPase"]
vesicle_trafficking["Vesicle
Trafficking"]
endocytosis["Endocytic
Pathway"]
autophagy["Autophagy
Regulation"]
ATG9A["ATG9A
Autophagy Gene"]
neuroprotection["Neuroprotective
Mechanisms"]
cellular_homeostasis["Cellular
Homeostasis"]
neurodegeneration["Neurodegeneration
Process"]
ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
dementia["Dementia
Disorders"]
FTD["Frontotemporal
Dementia (FTD)"]
MS["Multiple
Sclerosis (MS)"]
aging["Aging-Related
Decline"]
protein_aggregation["Protein
Aggregation"]
synaptic_dysfunction["Synaptic
Dysfunction"]
RAB5 -->|"activates"| vesicle_trafficking
RAB5 -->|"regulates"| endocytosis
RAB5 -->|"controls"| autophagy
RAB5 -->|"regulates"| ATG9A
vesicle_trafficking -->|"maintains"| cellular_homeostasis
endocytosis -->|"supports"| neuroprotection
autophagy -->|"clears"| protein_aggregation
RAB5 -->|"protects_against"| neurodegeneration
neuroprotection -->|"prevents"| synaptic_dysfunction
neurodegeneration -->|"manifests_as"| ALS
neurodegeneration -->|"manifests_as"| dementia
neurodegeneration -->|"manifests_as"| FTD
neurodegeneration -->|"manifests_as"| MS
aging -->|"accelerates"| neurodegeneration
protein_aggregation -->|"promotes"| synaptic_dysfunction
synaptic_dysfunction -->|"leads_to"| neurodegeneration
style RAB5 fill:#006494
style vesicle_trafficking fill:#1b5e20
style endocytosis fill:#1b5e20
style autophagy fill:#1b5e20
style neuroprotection fill:#1b5e20
style cellular_homeostasis fill:#1b5e20
style ATG9A fill:#4a1a6b
style neurodegeneration fill:#ef5350
style ALS fill:#5d4400
style dementia fill:#5d4400
style FTD fill:#5d4400
style MS fill:#5d4400
style aging fill:#5d4400
style protein_aggregation fill:#ef5350
style synaptic_dysfunction fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| vesicle trafficking | activates | pathway | 0.80 |
| Neurodegeneration | protects_against | process | 0.80 |
| neurodegeneration | protects_against | disease | 0.80 |
| NEURODEGENERATION | protects_against | gene | 0.80 |
| Neurodegeneration | associated_with | disease | 0.75 |
| Mapk | therapeutic_target | pathway | 0.70 |
| ATG9A | regulates | gene | 0.70 |
| VESICLE_TRAFFICKING | regulates | pathway | 0.68 |
| Als | transports | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Frontotemporal Dementia | causes | disease | 0.65 |
| Dementia | causes | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Ftd | causes | disease | 0.65 |
| Ms | causes | disease | 0.65 |
| Aging | encodes | disease | 0.65 |
| Neurodegeneration | encodes | disease | 0.65 |
| Als | encodes | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Ftd | therapeutic_target | disease | 0.65 |
| Ftd | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Neurodegeneration | implicated_in | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Frontotemporal Dementia | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| LC3 | interacts_with | protein | 0.70 |
| NEURODEGENERATION | associated_with | gene | 0.70 |
| MAP1LC3B | interacts_with | protein | 0.70 |
| PI3K | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| SNAP29 | therapeutic_target | gene | 0.60 |
| RAB3A | associated_with | gene | 0.60 |
| RAB3B | associated_with | gene | 0.60 |
| RAB10 | associated_with | gene | 0.60 |
| RAB11B | associated_with | gene | 0.60 |
| RAB5A | associated_with | gene | 0.60 |
| SYNAPTOPHYSIN | activates | gene | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| ATG9A | regulates | gene | 0.60 |
| PARKIN | regulates | gene | 0.60 |
| UBIQUITIN | regulates | gene | 0.60 |
| CHMP2B | causes | gene | 0.60 |
| FIG4 | causes | gene | 0.60 |
| ALS2 | causes | gene | 0.60 |
| IGF2BP1 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| C1Q/C3 | inhibits | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| LONP1 | associated_with | gene | 0.60 |
| CLPP | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| SQSTM1 | causes | gene | 0.60 |
| OPTN | causes | gene | 0.60 |
| C9ORF72 REPEAT EXPANSION | activates | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| ALS | therapeutic_target | gene | 0.60 |
| MOTOR NEURONS | causes | gene | 0.60 |
| C9ORF72 REPEAT EXPANSION | causes | gene | 0.60 |
| NEURON | protects_against | gene | 0.60 |
| C1Q | inhibits | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| CLPP | therapeutic_target | gene | 0.60 |
| RAB11 | inhibits | gene | 0.60 |
| STX17 | therapeutic_target | gene | 0.60 |
| RAB4B | associated_with | gene | 0.60 |
| RAB27B | associated_with | gene | 0.60 |
| RAB3C | associated_with | gene | 0.60 |
| OPTN | expressed_in | gene | 0.60 |
| ALS2 | expressed_in | gene | 0.60 |
| FIG4 | expressed_in | gene | 0.60 |
| C9ORF72 | protects_against | gene | 0.60 |
| SQSTM1 | expressed_in | gene | 0.60 |
| GAIN | protects_against | gene | 0.60 |
| ALS2 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuroscience | 2026-04-03 | 67 hypotheses Top: 1.000
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.732
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.69 · 2026-04-12
closed · Rounds: 7 · Score: 0.91 · 2026-04-10
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-03